Kitang, James .

HRN: 11-71-00  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2024
MUPIROCIN 2%, 15G (TUBE)
07/02/2024
07/09/2024
TOPICAL
As Needed
BID
DM Foot
Waiting Final Action 
07/02/2024
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/02/2024
07/09/2024
IV
1.5 Grams
Every 6 Hours
DM Foot
Waiting Final Action 
07/02/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/02/2024
07/09/2024
IV
600mg
Every 6 Hours
DM Foot
Waiting Final Action 
07/08/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/08/2024
07/08/2024
IV
4.5g
X 1 Dose
DM Foot
Waiting Final Action 
07/08/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/08/2024
07/15/2024
IV
2.25g
Q8h
DM Foot
Waiting Final Action 
07/13/2024
MUPIROCIN 2%, 15G (TUBE)
07/13/2024
07/20/2024
TOPICAL
2%
Bid
Infected Wound
Waiting Final Action 
07/17/2024
MUPIROCIN 2%, 15G (TUBE)
07/17/2024
07/24/2024
TOPICAL
Thin Application
BID
Infected Wound
Waiting Final Action 
07/22/2024
MUPIROCIN 2%, 15G (TUBE)
07/22/2024
07/29/2024
TOPICAL
Thin Application
Bid
Infected Wound
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: